Share on LinkedInShare on LinkedIn

ARTICLE · 11 JANUARY 2023

FDA Issues Final Guidance On GRAS Panel Best Practices

On December 20, the FDA issued the final guidance document, "Best Practices for Convening a GRAS Panel."

United StatesFood, Drugs, Healthcare, Life Sciences
  • On December 20, the FDA issued the final guidance document, "Best Practices for Convening a GRAS Panel." A "GRAS panel" means a panel of qualified experts who independently evaluate whether the available scientific data, information, and methods establish that a substance is safe under the conditions of its intended use in human food or animal food as part of a Generally Recognized As Safe (GRAS) determination.
  • In most cases, a substance's GRAS status can be determined without a GRAS panel if the safety of the substance is supported by evidence of general acceptance. For example, peer-reviewed primary safety studies or secondary reviews of primary literature may provide evidence of general acceptance. However, the guidance explains the value of a GRAS panel in providing evidence to support "general acceptance," and also highlights best practices to help those interested in convening a GRAS panel:
    • Identify GRAS panel members who have appropriate

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from